Owners, management and financials
CVR: 44285584
Secondary names: OmicVision Denmark ApS, Resolute Bio ApS, OmicVision ApS
DKK 3,582,426
Gross profit
Net result: DKK -4,415,945
VOMA HOLDING A/S (33,33-49,99%), AM Tech Ventures ApS (15-19,99%)
2 more
CVR · view owners
Ishani Tara Ummat, Andreas Mund
1 more in management
Board: Ole Vorm (chair) and 2 members
CVR · view management
Active
Founded 1 September 2023
CVR · view overview
17 employees
CVR · 2026
Owner registered: VOMA HOLDING A/S
CVR · 30/08/2024
View the full event history
OmicVision Biosciences ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ishani Tara Ummat, Andreas Mund and Maximilian Thomas Dr Strauss. The board consists of Ole Vorm (chair), Andreas Mund and Maximilian Thomas Dr Strauss. The company's owners include VOMA HOLDING A/S, AM Tech Ventures ApS and MS Ventures ApS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 3,582,426 and a net result of DKK -4,415,945. Equity in the 2025 report amounted to DKK 117,378.
Selskabets formål er at drive bioteknologisk forskning og udvikling af diagnostik til kræft og andre sygdomme, samt hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 3.6M | -4.4M | 12.3M | 117K | 9 |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of OmicVision Biosciences ApS is 44285584.
The owners of OmicVision Biosciences ApS include VOMA HOLDING A/S, AM Tech Ventures ApS and MS Ventures ApS.
The management of OmicVision Biosciences ApS consists of Ishani Tara Ummat, Andreas Mund and Maximilian Thomas Dr Strauss.
The board of OmicVision Biosciences ApS consists of Ole Vorm, Andreas Mund and Maximilian Thomas Dr Strauss, with Ole Vorm as chair.
In 2025, OmicVision Biosciences ApS reported a gross profit of DKK 3,582,426.
OmicVision Biosciences ApS had 17 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 31849498, new email: [email protected], new website: www.omicvision.com (October 12, 2026).
Address changed to Ryesgade 113, 2100 København Ø (June 9, 2026).
Contact info changed: new phone: 31849498, new email: [email protected], new website: www.omicvision.com (June 9, 2026).
OmicVision Biosciences ApS has published its annual report for 2025. Gross profit came to DKK 3,582,426, and the net result was DKK -4,415,945.
Contact info changed: new phone: 26332323, new email: [email protected], new website: www.omicvision.com (May 4, 2026).
Contact info changed: new phone: 26332323, new email: [email protected], new website: www.omicvision.com (March 16, 2026).
OmicVision Biosciences ApS has published its interim report for the period September 1, 2023 to December 31, 2024.
As of August 30, 2024, VOMA HOLDING A/S is registered as an owner of OmicVision Biosciences ApS with an ownership share of 33%.
As of August 30, 2024, AM Tech Ventures ApS is registered as an owner of OmicVision Biosciences ApS with an ownership share of 15%.
As of August 30, 2024, MS Ventures ApS is registered as an owner of OmicVision Biosciences ApS with an ownership share of 15%.
As of August 30, 2024, Ummat Ventures ApS is registered as an owner of OmicVision Biosciences ApS with an ownership share of 10%.
As of May 1, 2024, Ishani Tara Ummat is registered as adm. dir. of OmicVision Biosciences ApS.
As of December 1, 2023, DANSK REVISION ODENSE GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of OmicVision Biosciences ApS.
As of December 1, 2023, Ole Vorm has joined the board of directors of OmicVision Biosciences ApS.
As of December 1, 2023, Andreas Mund has joined the board of directors of OmicVision Biosciences ApS.
As of December 1, 2023, Maximilian Thomas Dr Strauss has joined the board of directors of OmicVision Biosciences ApS.
As of September 1, 2023, Andreas Mund is registered as director of OmicVision Biosciences ApS.
As of September 1, 2023, Maximilian Thomas Dr Strauss is registered as director of OmicVision Biosciences ApS.
OmicVision Biosciences ApS was founded on September 1, 2023.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 29418888
CVR 29769796
CVR 34688605
CVR 34892970
CVR 35047565
